Kedcyla 160mg Trastuzumab Injection



Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body’s immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

Product Specification

Packaging Size 1 injection
Brand Kedcyla 160mg
Composition Trastuzumab Emtansine
Manufacturer Rouch (imported from Turkey)
Treatment Breast Cancer